Results 241 to 250 of about 3,668,573 (294)
Some of the next articles are maybe not open access.
CRC Critical Reviews in Clinical Laboratory Sciences, 1980
It has been more than 30 years since Dr. H. S. Lawrence first reported that it was possible to transfer delayed-type hypersensitivity from sensitized donors to unsensitized recipients with lysates of blood leukocytes. During recent years, research from several laboratories has demonstrated that this effect is immunologically specific.
Charles H. Kirkpatrick, Denis R. Burger
openaire +3 more sources
It has been more than 30 years since Dr. H. S. Lawrence first reported that it was possible to transfer delayed-type hypersensitivity from sensitized donors to unsensitized recipients with lysates of blood leukocytes. During recent years, research from several laboratories has demonstrated that this effect is immunologically specific.
Charles H. Kirkpatrick, Denis R. Burger
openaire +3 more sources
Southern Medical Journal, 1975
Dialyzable transfer factor, obtained from human peripheral blood leukocytes and first described by Lawrence, is being used in attempts to rectify defects in the cellular immune systems of patients with basic immunodeficiencies, chronic infectious diseases, and neoplastic diseases.
openaire +2 more sources
Dialyzable transfer factor, obtained from human peripheral blood leukocytes and first described by Lawrence, is being used in attempts to rectify defects in the cellular immune systems of patients with basic immunodeficiencies, chronic infectious diseases, and neoplastic diseases.
openaire +2 more sources
Purification of transfer factors
Molecular Immunology, 1992Transfer factor activities have been studied in both clinical and basic science settings for several decades. Until now, highly purified transfer factors that are suitable for molecular analysis have not been available. This has impeded progress towards understanding the molecular and cellular basis of the activities of these important inducers of cell-
S J, Rozzo, C H, Kirkpatrick
openaire +2 more sources
Factorizations of Transfer Functions
SIAM Journal on Control and Optimization, 1980This paper is concerned with minimal factorizations of rational matrix functions. The treatment is based on a new geometrical principle. In fact, it is shown that there is a one-to-one correspondence between minimal factorizations on the one hand and certain projections on the other.
Bart, H. +3 more
openaire +2 more sources
The Lancet, 1973
Abstract Leucocytes obtained from a donor sensitive to Candida antigen contain a factor (transfer factor) which transfers this sensitivity to non-sensitive recipients. This material is present in the dialysate of leucocyte lysates and can be purified therefrom by gel filtration. This immunologically active component of transfer factor seems to be more
A A, Gottlieb +3 more
openaire +2 more sources
Abstract Leucocytes obtained from a donor sensitive to Candida antigen contain a factor (transfer factor) which transfers this sensitivity to non-sensitive recipients. This material is present in the dialysate of leucocyte lysates and can be purified therefrom by gel filtration. This immunologically active component of transfer factor seems to be more
A A, Gottlieb +3 more
openaire +2 more sources
Transfer Factor in Atopic Dermatitis
Dermatology, 1982Dialyzable leukocyte extract (transfer factor, TF) from unselected healthy blood donors was given every other week during 1 year to adult patients with severe atopic dermatitis. The results from this double-blind investigation did not reveal any clinical benefit of TF therapy.
Cramers, Marie +5 more
openaire +2 more sources
1994
Cell-mediated immunity (CMI) plays an important role in controlling the proliferation of tumor cells. Since transfer factor (TF) is reportedly able to increase CMI, it was tempting to plan clinical trials whereby transfer factor could be used to increase cancer patients’ cellular immune response to their tumor cells.
G, Pizza, C, De Vinci, H H, Fudenberg
openaire +2 more sources
Cell-mediated immunity (CMI) plays an important role in controlling the proliferation of tumor cells. Since transfer factor (TF) is reportedly able to increase CMI, it was tempting to plan clinical trials whereby transfer factor could be used to increase cancer patients’ cellular immune response to their tumor cells.
G, Pizza, C, De Vinci, H H, Fudenberg
openaire +2 more sources